This quality outcomes database study finds C7-T1 fusion improves QALY and reduces readmission rates in patients undergoing ACDF, indicating positive implications for surgical counseling.
Background: The C7-T1 segment poses challenges in spinal surgery due to its biomechanical transition from the mobile cervical spine to the rigid thoracic spine, with concerns about subsidence from stress-shielding of the T1 superior endplate by the first rib. The impact of fusing C7-T1 on outcomes remains unclear relative to other levels during anterior cervical discectomy and fusion (ACDF). Objective: In a cohort of patients undergoing ACDF, we sought to determine the impact of C7-T1 fusion on patient-reported outcome measures (PROMs) and clinical outcomes. Methods: A retrospective cohort study using the Quality Outcome Database was conducted for patients who underwent primary single- or 2-level ACDF. The primary exposure variable was fusion of C7-T1. The primary outcome was 3-month and 12-month PROMs, including numeric rating scale for neck and arm pain, neck disability index, quality-adjusted life year (QALY) score, and patient satisfaction. Secondary outcomes included 30-day complications and 3-month readmissions and reoperations. Multivariable regression models were fitted for each outcome, controlling for baseline variables. Results: Of 12,240 patients (age 55.8 ± 11.6 years; 48.7% male) undergoing ACDF, 4736 (38.7%) had C7-T1 fusion. On multivariable regression, fusion of C7-T1 was associated with a greater 3-month QALY score (odds ratio [OR] = 1.142; 95% confidence interval [CI]: 1.055–1.237; p < 0.001) and lower rate of readmission (OR = 0.760; 95% CI: 0.625–0.924; p = 0.006), with no association to other PROMs, patient satisfaction, complications, and reoperation ( p > 0.05). On subanalysis of 4103 myelopathic patients, C7-T1 fusion was only associated with lower odds of 3-month readmission (OR = 0.602; 95% CI: 0.420–0.864; p = 0.006). Conclusion: C7–T1 fusion was associated with a better 3-month QALY score and a lower rate of readmission. Myelopathy patients with C7-T1 fusion were also less likely to be readmitted within 3 months of surgery. C7-T1 fusion was not associated with any other outcome. Our results suggest comparable outcomes when fusing C7-T1, which may be useful when counseling patients facing surgery for pathology at this level.
No takes yet. Share an insight, caveat, or question.
Zakieh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: